Glucose as a Major Antioxidant: When, What for and Why It Fails? by Cherkas, Andriy et al.
antioxidants
Review
Glucose as a Major Antioxidant: When, What for and
Why It Fails?
Andriy Cherkas 1,*,† , Serhii Holota 2,3 , Tamaz Mdzinarashvili 4, Rosita Gabbianelli 5 and
Neven Zarkovic 6
1 Department of Internal Medicine # 1, Lviv National Medical University, 79010 Lviv, Ukraine
2 Department of Pharmaceutical, Organic and Bioorganic Chemistry, Lviv National Medical University,
79010 Lviv, Ukraine; golota_serg@yahoo.com
3 Department of Organic Chemistry and Pharmacy, Lesya Ukrainka Eastern European National University,
43025 Lutsk, Ukraine
4 Institute of Medical and Applied Biophysics, I. Javakhishvili Tbilisi State University, 0128 Tbilisi, Georgia;
tamaz.mdzinarashvili@tsu.ge
5 Unit of Molecular Biology, School of Pharmacy, University of Camerino, 62032 Camerino, Italy;
rosita.gabbianelli@unicam.it
6 Laboratory for Oxidative Stress (LabOS), Institute “Rudjer Boskovic”, HR-10000 Zagreb, Croatia;
zarkovic@irb.hr
* Correspondence: cherkasandriy@yahoo.com
† Present address: Team Early Projects Type 1 Diabetes, Therapeutic Area Diabetes and Cardiovascular
Medicine, Research & Development, Sanofi-Aventis Deutschland GmbH., Industriepark Höchst-H831,
Frankfurt am Main 65926, Germany; andriy.cherkas@sanofi.com.
Received: 10 December 2019; Accepted: 3 February 2020; Published: 5 February 2020


Abstract: A human organism depends on stable glucose blood levels in order to maintain its metabolic
needs. Glucose is considered to be the most important energy source, and glycolysis is postulated
as a backbone pathway. However, when the glucose supply is limited, ketone bodies and amino
acids can be used to produce enough ATP. In contrast, for the functioning of the pentose phosphate
pathway (PPP) glucose is essential and cannot be substituted by other metabolites. The PPP generates
and maintains the levels of nicotinamide adenine dinucleotide phosphate (NADPH) needed for the
reduction in oxidized glutathione and protein thiols, the synthesis of lipids and DNA as well as
for xenobiotic detoxification, regulatory redox signaling and counteracting infections. The flux of
glucose into a PPP—particularly under extreme oxidative and toxic challenges—is critical for survival,
whereas the glycolytic pathway is primarily activated when glucose is abundant, and there is lack of
NADP+ that is required for the activation of glucose-6 phosphate dehydrogenase. An important role
of glycogen stores in resistance to oxidative challenges is discussed. Current evidences explain the
disruptive metabolic effects and detrimental health consequences of chronic nutritional carbohydrate
overload, and provide new insights into the positive metabolic effects of intermittent fasting, caloric
restriction, exercise, and ketogenic diet through modulation of redox homeostasis.
Keywords: glucose; pentose phosphate pathway; NADPH; redox balance; glycogen; glycolysis; stress
resistance; insulin resistance
1. Introduction
The glucose level in blood is one of the most important homeostatic parameters and is strictly
regulated [1]. The complex interplay of signals from central and autonomic branches of the nervous
system, and the impact of multiple hormones and cytokines, all support coordinated glucose flows
within the body according to the actual needs and availability, in order to maintain its concentration in a
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narrow range [2]. Since severe alterations of glucose metabolism take place in many diseases—including
diabetes, that affects hundreds of millions of patients worldwide—there is a wealth of information
about health effects and biochemical changes due to high (over 10.0 mM) or low (under 3.5 mM) glucose
levels. The pathways of glucose metabolism and its regulation such as glycolysis/glycogenolysis,
pentose phosphate pathway (PPP), gluconeogenesis, polyol pathway, insulin signaling pathway and
many others are very well studied and their physiology and pathophysiology are firmly established.
It is well documented that hyperglycemia is associated with oxidative stress and that the severity of
diabetes correlates with the levels of accumulation of lipid peroxidation products, oxidatively modified
proteins and advanced glycation products; therefore, glucose itself is recognized by many prooxidant
factor. Short-time higher than physiological glucose levels (more than 10.0 mM) cause certain degree of
damage due to increased rate of non-enzymatic glycation of proteins but are usually not life-threatening
if blood glucose does not exceed 20.0 mM and is associated with diabetic ketoacidosis due to insulin
insufficiency. In contrast, low blood concentrations (2.5 mM and lower) can cause severe brain damage
and potentially death within the periods of time as short as 5–6 h [3]. Brain and particularly neurons
are the most sensitive to glucose deprivation, while other tissues and cells show a wide divergence in
resistance to hypoglycemia [1] that is very much dependent on their function, peculiarities blood flow
and capability to store glucose in the form of glycogen.
In the present review we would like to focus on the other aspects of glucose metabolism that are
not sufficiently addressed in the literature, namely physiological aspects of involvement of glucose and
its stores in the form of glycogen in regulation/maintenance of redox balance in cells and tissues. The
role of glucose as a fundamental source of reducing equivalents to antioxidant intracellular machinery
very often underestimated or ignored due to its reputation of primary source of energy. Understanding
the involvement of glucose in redox processes will enable not only better explanation of its metabolic
role, but also will open new possibilities to address poorly understood nature of insulin resistance,
and metabolic changes in diabetes overall. Our interpretation is also consistent with the mounting
epidemiological evidence and can explain deleterious health effects of excessive dietary consumption
of carbohydrates and sedentary lifestyle.
2. Basic Overview of Glucose Metabolism and Its Role in Maintenance of Redox Balance
It is well-known that most of the glucose in human metabolism is utilized intracellularly in
glycolytic pathway with further degradation of products in the tricarboxylic acid (TCA) cycle in order
to produce NADH and ATP [4]. Glycolysis is effectively activated by insulin in conditions of glucose
abundance, and a number of intermediates are also used for synthesis of needed amino and fatty
acids as well as other important metabolites [2]. However, in conditions of limited glucose supply
and/or excessive metabolic needs there are numerous alternative ways to generate enough NADH
and ATP, for example by the oxidation of fatty and amino acids, and the utilization of ketone bodies.
Flexibility and interchangeability of cellular energy supply provides sustainable and at the same time
variable flow of metabolites that is capable to accumulate them when the nutrients are in abundance
and consume them in a most effective way when there is their deficit. In periods of starvation or
glucose deficit, the activation of catabolic programs is capable to maintain energy production in most
of the organs [5]. Since neurons do not accumulate glycogen and total accumulation of glycogen in
central nervous system being extraordinarily low is limited to astrocytes, neurons rely on glucose
supply from the bloodstream [6]. Interestingly, in periods of starvation the brain can effectively use
ketone bodies as a primary fuel accounting for more than 75% of its energetic needs, pointing out the
possibility that glucose may be used for other purposes in this case [7]. This is further confirmed by
the observation that glycolysis in neurons is actively downregulated by proteasomal degradation of
6-phosphofructo-2-kinase/fructose-2,6-bis- phosphatase-3, preventing the utilization of glucose for
bioenergetics purposes. This mechanism, as suggested by authors, spares glucose in neurons for
maintaining antioxidant status, especially in conditions of limited glucose supply [8].
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The importance of other major pathway of glucose metabolism, which to certain degree is an
alternative or parallel to upper glycolysis, a pentose phosphate pathway (PPP) is also long known. It
is believed that its major function is the generation of reducing equivalents in the form of NADPH
needed for de novo lipogenesis, synthesis of DNA and aromatic amino acid [9]. Indeed, proliferating
cells use most of the NADPH for DNA and fatty acid synthesis [10]. The other major functions of
NADPH are the reduction in oxidized thiols and glutathione, generation of superoxide anion and
hydrogen peroxide during respiratory burst to fight infections and to provide redox signals to regulate
cell functions. In addition, it is also needed for detoxification of xenobiotics [11]. A growing number of
publications point out rerouting of glucose into a PPP as a major protective mechanism employed to
counteract acute and severe oxidative stress [9,12,13]. According to the calculations, the full oxidation
of one molecule of glucose in the PPP yields 12 molecules of NADPH reduced from NADP+ [14].
This aspect highlights the extraordinary efficiency and prompt responsiveness of this mechanism
in balancing redox homeostasis in conditions of acute oxidative challenge. Indeed, activation of
redox-sensitive transcription factors such as Nrf2 or FOXOs, in response to oxidative stress will result
in induction of antioxidant enzymes within hours [15], while rerouting of glucose into the PPP to
generate reducing power for antioxidant enzymes takes place almost immediately [14]. With the use
of 13C flux analysis in neurons, it was recently shown that glucose metabolism through the PPP may
be much more significant than was previously estimated [16]. Moreover, the authors demonstrated
that about 73% of produced labeled pyruvate was exported from neurons as lactate [16]. This may
indicate that neurons remove glucose that cannot be fully utilized in TCA away from the cells. In
case of increased functional activity, oxidative stress or glucose deficit during starvation, most of the
glucose flux may be redirected into the PPP.
The PPP is a major source of NADPH; however, it is not the only one. Substantial amounts of
NADPH are generated in folate-dependent NADPH-producing pathway [10] as well as by cytosolic
isocitrate dehydrogenase and malic enzyme [11]. However, these sources are often coupled with
synthetic pathways; for example, isocitrate is in abundance when glycolysis is activated and contributes
to fatty acid synthesis, therefore, it is difficult to expect their substantial contribution to the regeneration
of NADPH in cases of oxidative stress. To a certain degree, the metabolism of amino acids can
compensate for functional lack of glucose, and contribute to the maintenance of NADPH, but this seems
to be the mechanism with limited power under extreme exposures. Noteworthily, recently it was shown
that malic enzyme and 6-phosphogluconate dehydrogenase (6PGD) form a hetero-oligomer to promote
the activity of 6PGD, independently on activity of malic enzyme [17]. It is likely that the other structural
and functional interactions may exist in the cells in order to couple synergistic metabolic processes
in response to oxidative stress. The activity of alternative pathways provides robustness of NADPH
supply and, to some extent, compensates for the deficit of PPP flux in patients with glucose-6 phosphate
dehydrogenase (G6PD) deficiency—one of the most common genetic diseases in humans [18]. Patients
with G6PD deficiency generally have no symptoms and their lifespan is not affected by disease, but
it was shown that in addition to increased hemolysis they are less resistant to some poisonings [18]
and have higher risk of diabetes and metabolic syndrome [19]. Glucose-6 phosphate (G6P) is an
exclusive substrate for G6PD, a rate limiting enzyme of the PPP that can be supplied from extracellular
space in the form of glucose, then phosphorylated by hexokinase in human organisms. Alternatively,
glucose-1 phosphate released from glycogen—if the latter is available in the cell—is converted by
phosphoglucomutase to G6P. Some tissues—namely in the liver, kidneys or intestine [7], and to some
extent the glial cells—can generate glucose via gluconeogenesis. Furthermore, tumor cells may reverse
glycolysis in order to maintain their biosynthesis in glucose-free conditions [20]. Noteworthily, the
expression of most of the enzymes in the PPP is controlled by Nrf2, a redox sensitive transcription
factor involved in the upregulation of antioxidant and detoxifying genes, the degradation of damaged
proteins and metabolic reprogramming during stress [21], pointing out the tight conjugation of redox
balance maintenance and glucose metabolism. In other words, on the cellular and organism levels,
responses to local or systemic oxidative stress are associated with increased glucose release/production
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by the liver and subsequently hyperglycemia, which may be physiological adaptive response in healthy
subjects and may also take place as a chronic metabolic deterioration in diabetic patients.
3. Oxidative PPP Is Thermodynamically More Favorable Compared to Upper Glycolysis under
Conditions of Limited Glucose Supply
In physiological conditions (without metabolic/oxidative stress) the ratio of reduced and oxidized
forms of this coenzyme NADPH/NADP+ is very high (in the range of approximately 100/1, but is highly
tissue-dependent) and the lack of free NADP+ prevents G6P from entering the PPP [14]. However,
as soon as NADPH is oxidized (e.g., in conditions of oxidative stress) the increased availability of
NADP+ immediately redirects metabolic flow to the PPP and suppresses further steps of glycolysis
and the downstream utilization of glucose metabolites in TCA [8,13]. In other words, cells prioritize
the metabolism of glucose through the PPP over standard reactions of upper glycolysis in order to
maintain a sufficient NADPH/NADP+ ratio needed for the counteraction of acute oxidative challenge
(prompt enzymatic reduction in glutathione and other oxidized thiols), biosynthesis and/or generation
of superoxide during immune responses or as physiological redox signaling (Figure 1). Glucose
availability for the PPP—either from extracellular space, or from intracellular glycogen stores—is
essential for acute antioxidant responses ensuring the survival of cells and organism(s) in extreme
conditions. Stable and robust liver glucose output in cases of severe stress (including oxidative stress),
infection, starvation and extreme exercise is protected by the development of insulin resistance in order
to provide sufficient glucose flow to balance redox homeostasis. In absolute quantities, especially at rest,
glucose flow into the PPP may be low compared to standard upper glycolysis, but under conditions
when the NADPH/NADP+ ratio drops, amounts of glucose entering the PPP will correspond to the
degree of NADPH depletion.
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utilization through glycolysis in physiological conditions takes place when the NADPH/NADP+ ratio
is high (usually 50–100/1), glucose is relatively abundant and the insulin signaling is not compromised.
Glycolysis serves as a source of pyruvate for TCA cycle and a number of anabolic intermediates in
conditions of high carbohydrate availability, and is supposed to be fully activated only occasionally
under physiological conditions, often switching to the oxidation of fatty acids when glucose availability
is limited. This shift takes place in concert with activation of transcription factors involved in
antioxidant defense (for example Nrf2 and isoforms of FOXO transcription factor) as a part of systemic
antioxidant response aimed to balance redox homeostasis, where gluconeogenesis and activation of the
PPP are fundamental parts of it (Figure 2). A sedentary lifestyle plus an abundance of carbohydrates
in food lead to an imbalance of nutritional consumption and actual metabolic needs; therefore, redox
dysregulation contributes to metabolic syndrome and diabetes type 2, and is an important factor that
increases the incidence of cancer that is discussed in more detail in the next section.
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Figure 2. Glucose availability is a major factor in the maintenance of redox homeostasis through the
reduction in oxidized NADP+, which is used for the subsequent reduction in oxidized glutathione
and thiols. At the same time NADPH is used for synthesis of DNA and fatty acid synthesis and
is needed for activities of NADPH oxidases, NO-synthase and other processes. The scheme is
simplified and regulatory networks functioning in living systems are much more complex and include
other mechanisms and feedback loops. For example, it was recently shown that the deletion of
Nrf2 in mice can be—to a large extent—compensated by other adaptive mechanisms in conditions
of caloric restriction [23]. This suggests that robust regulatory network beyond Nrf2 and FOXO
transcription factors exists in order to maintain redox balance. Abbreviations: PPP—pentose
phosphate pathway, NOX—NADPH oxidase, NOS—nitric oxide synthase, GSH—glutathione,
GSSG—glutathione disulfide, Pr—protein, PrSSPr—disulfide bonds between/within the proteins
and other molecules, ARE—antioxidant response element, InsR—insulin receptor, cAMP—cyclic
adenosine monophosphate, FOXO—forheadkbox O transcription factors, Prx3—peroxiredoxin 3,
Nrf2—Nuclear factor (erythroid-derived 2)-like 2 transcription factor, MnSOD—manganese superoxide
dismutase, NF-kB—nuclear factor kappa-light-chain-enhancer of activated B cells.
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4. The Epidemiological Evidence of Glucose Overload in Human Population: Current vs.
Historical Nutritional/Behavioral Patterns and a Growing Potential of Pharmacological
Interventions
As currently observed, massive nutritional carbohydrate overload associated with dramatic
decreases in physical activity has caused an epidemic of non-communicable diseases such as obesity,
metabolic syndrome, type 2 diabetes, atherosclerosis, hypertension and cancer [24]. A large-scale
epidemiological cohort study pointed out that high carbohydrate consumption is a major factor for
all-cause mortality, while different types of fat were not associated with increased mortality. Thus,
authors question the current dietary guidelines suggesting an urgent need for their reconsideration [25].
On the other hand, the results of a large prospective cohort study indicate that health outcomes
depend rather on quality of food rather than just limiting carbohydrate or saturated fat in the diet. In
addition, “unhealthy” low carbohydrate and/or fat diet may increase all-cause mortality in studied
population [26]. Together with other evidences, including numerous animal studies, a serious demand
for strategies on how to counteract carbohydrate overload is indicated. Different approaches, including
pharmacological interventions [27] as well as public health and food regulation policies, are increasingly
discussed in the literature [28]. The careful evaluation of multiplicity of factors must be in place
in order to determine the optimal nutritional pattern for health preservation and the prevention of
age-related diseases.
In fact, an abundance of carbohydrates in food during human evolution was rather rare and more
of a short-term and often seasonal luxury [29]. Human neonates grow very rapidly and their need for
carbohydrate supply is probably higher than in adults than in other species due to the relatively large
brain and rapid development of the nervous system; however, human breast milk “only” contains
about 6.7 g per 100 mL of lactose accounting for up to 40% of calories—still the highest compared
to other mammals [30,31]. It is not likely that adults need more carbohydrates than babies as a
percent of calories intake in usual conditions without regular vigorous physical activity. The excessive
consumption of carbohydrates and low physical activity are major contributors to increasing rates of
metabolic syndrome and obesity in children and adolescents [32].
At high growth rate, the intensive physical activity as well as strong immunity needed for
resistance to infections and occasional poisonings requires the maintenance of sufficient levels of
glucose in blood, despite prolonged periods of carbohydrate deficit. Dietary glucose—as well as other
carbohydrates—were precious food components with limited, often seasonal availability promoting
survival under extreme conditions [29]. Therefore, an evolutionary sweet taste developed to detect
sources of digestible carbohydrates [33]. Only the development of agriculture about 10,000 years ago
enabled higher consumption of grain, increasing the share of carbohydrate in the diet. Even though
carbohydrates became more available, any possible overload would rather not take place considering
intensive physical activity of most of the people at that time. Thus, the gradual increase in basic food
availability and elimination of physical work created a massive nutritional carbohydrate overload at
the organism’s level causing respective health consequences [25]. Consistent with this, a metabolic
core model was recently used to evaluate how increased glycolytic utilization of glucose together with
glutamine-dependent lactate production promotes cancer growth [34]. Hyperglycemia may directly
contribute to increased risk of cancer as it was recently shown by Wu et al. [35]. Overall, there is
growing evidence—both mechanistic and epidemiological—that confirms previous predictions of
interrelationships between risk of cardiovascular/metabolic diseases and cancer risks [36–38].
Consistent with this is recent data generated on a C. elegans model regarding the integration of
stress-induced responses of nervous system with metabolic adaptations [39]. It was shown that the flight
response mediated by tyramine (worm analog of catecholamines) in the end leads to the stimulation of
insulin-IGF-1 signaling and has the opposite effect to longevity-promoting stress responses to heat,
starvation, glucose restriction or exercise [40–42]. If hypothetically translated to modern humans,
it can provide accurate mechanistical explanations as to why emotional stress accompanied with
sedentary behaviors may have detrimental health consequences associated with both excessive insulin
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and adrenaline signaling causing atherosclerosis [24], contributing among the other factors to insulin
resistance and accelerated aging [43], but can be reversed by exercise or fasting [44]. In this sense
psycho-emotional stress prepares the organism to the impact of “expected” extreme factor in near
future, and in cases of “false alarms”, the excess of glucose needs to be utilized by the activation of
insulin signaling contributing to pathologic continuum that leads to atherosclerosis [24].
In regard to glucose balance/overload and its crucial role in metabolic diseases, new data obtained
in clinical trials is very important, where patients were exposed to sodium glucose co-transporter
2 (SGLT-2) inhibitors. Designed initially to improve glycemia in patients with type 2 diabetes that
are not optimally controlled by metformin monotherapy—canagliflozin, dapagliflozin, empagliflozin
and others are continuously surprising clinicians and researchers by new positive effects far beyond
glycemia, including—but not limited to—the improvement of insulin resistance, reducing body
weight [45], preventing acute cardiovascular events [46], exerting a normalizing effect on blood
pressure, kidney function [47] and reversing manifestations of heart failure [46]. A plethora of positive
effects convincingly confirmed in strictly controlled clinical trials according to the highest standards of
evidence-based medicine by simply getting rid of approximately 50–70 g of (excessive) glucose per
day makes a significant difference for patients, and may potentially find its place among preventive
interventions. It is worth pointing that some contribution to the effect may potentially come from
sodium reabsorption inhibition, however, it is clear that the role of glucose excretion is prominent.
Thus, from the evolutionary point of view, the human organism was rather not used to the
consumption of large amounts of glucose and has had to optimize its metabolism in order to be able
to produce its sufficient amounts in accordance with metabolic needs. The importance of the PPP
evolved in order to provide resistance to oxidative challenges that are crucial for survival in acute
extreme conditions in multicellular organisms. The upregulation of PPP under oxidative stress is tightly
coupled with enhanced glucose output from glycogen stores and/or stimulation of gluconeogenesis.
Glucose 6-phosphate is a specific substrate for the PPP that makes glucose so important and strictly
regulated in maintaining redox homeostasis in human organisms [1].
5. Glycogen Protects against (Not Only) Oxidative Stress
According to our hypothesis, availability of intracellular glycogen is supposed to be protective
against oxidative stress, and vice-versa; its absence exposes cells to higher risk. Indeed, neurons,
which are unable to accumulate glycogen appear to be among the most sensitive cells to oxidative
stress, and they apply sophisticated mechanisms to direct the flow of glucose into the PPP in order
to protect themselves [8]. Severe hypoglycemia may result in seizures, loss of consciousness, coma
and—if glucose is not administered/ingested for longer periods (more than 5–6 h)—death [48]. Very
similar clinical manifestations have been observed in cases of hyperbaric oxygen exposure (so called
oxygen poisoning) that also causes severe redox imbalance in brain [49].
A recent C. elegans study demonstrated the crucial role of glycogen stores in resistance to acute
oxidative stress [50]. Moreover, the excessive accumulation of glycogen from a high-glucose diet and
with impaired glycogen degradation resulted in decreased lifespan of the worms [50]. Insecticide
poisonings causing oxidative stress in the fruit-eating bat Artibeus lituratus causes glycogen stores
depletion [51]. It was recently shown that hawkmoths, who have one of the highest metabolic rates
among known animals, use nectar sugar directed through the PPP to counteract oxidative damage
resulting from flight (extremely intensive exercise) [52]. In humans, the inability to deplete muscular
glycogen in patients with glycogen phosphorylase deficiency (McArdle disease) is associated with
severe exercise-induced oxidative stress and a risk of rhabdomyolysis [53]. This points out the
possibility that the function of glycogen in muscles is not only as an energy store during periods of
intensive contraction, but also for counteracting oxidative challenges associated with exercise.
It was noted that main life- and health-span promoting interventions such as caloric restriction,
intermittent fasting and exercise have in common that the depletion of glycogen stores [44], thus
reducing the protective capacity of glycogen and exposing the cells to moderate hormetic oxidative
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stress. Glycogen stores are not simply an intracellular source of glucose, they also have an important
signaling function [54] and are protective against a number of stressful situations, namely hyper/hypo
osmotic stress [55], anoxia/hypoxia [56]. In addition, growing evidence indicates that a metabolic switch
from utilization of glucose, which is abundant in western diets, to ketone bodies use derived from
fatty acids is an evolutionarily conserved trigger-point responsible for health effects from intermittent
fasting, caloric restriction and exercise [57]. Furthermore, a complex interplay of hormones including
insulin, glucagon, leptin, adiponectin and others regulate metabolic adjustments in conditions of food
abundance and deficit to provide needed glucose levels and energy in the organism [58–60].
6. Epigenetics and Posttranslational Protein Modification Modulate Oxidative Stress Responses
Epigenetics regulates gene expression, modifying DNA methylation and chromatin structure.
This regulatory mechanism works differently in each tissue to guarantee specific genetic responses
to environmental factors (i.e., nutrition, chemicals, stress), without any changes in the sequence of
nucleotides [61,62]. Epigenetics plays a key role starting from early life, where it is the master director
of cell differentiation, X-inactivation and the programming of adult health [63]; epigenetic changes can
be transferred to the progenies and, sometimes, they can be reverted [64].
DNA methylation consists of the methylation of Cytosine at CpG islands in the promoter region of
genes which has been associated with gene silencing, while different responses (activation or inhibition
of gene expression) derives from the methylation of CpG islands located in the regulatory regions
of genes. Histone modifications are changes that are more complex, because functional groups (i.e.,
acetyl, methyl, P, etc.) deriving from oxidation of nutrients, can be added to histones’ amino acid
residues, thus remodeling chromatin. The final result of histone modification is chromatin remodeling
at specific genes, leading to increased/decreased gene expression associated with healthy or unhealthy
regulatory responses [63].
Oxidative stress related with metabolic responses linked to hyperglycemia can enhance DNA
methylation interfering with S-adenosyl-L-methionine (SAM), the key methyl donor for the DNA
methyltransferases (DNMTs) which catalyze CpG methylation [65]. In particular, the deprotonation
by superoxide anion of cytosine C5 at CpG islands can support the formation of DNA-SAM complex
leading to the final cytosine methylation; furthermore, DNA methylation has been associated with the
increase in DNMT1 and DNMT3B expression due to reactive oxygen species (ROS) [65,66]. Glucose
can mediate epigenetic modification not only through ROS, but also because the high level of glucose
can interfere with DNA demethylation via TET2 and AMPK [67].
However, oxidation at the level of guanine leading to 8-hydroxydeoxyguanosine (8-OHdG)
in CpG islands, can also decrease cytosine methylation and reduce the binding of transcription
factors to the promoter region. The oxidation of 5-methylcytosine (5mC) due to Ten-Eleven
Translocation (TET) proteins leads to 5-hydroxymethylcytosine (5hmC) formation, which is deaminated
to 5-hydroxymethyluracil and then replaced with unmethylated cytosine [68]. Oxidative stress can
also inhibit the NAD+ dependent deacetylase SIRT1 that controls inflammatory responses, lipid
storage, telomerase activity, mitochondrial respiration and ROS production [69,70]. In this context, a
high-fat/glucose diet that decreases NAD+ content can negatively regulate Sirtuin activity.
The regulation of responses to oxidative stress is complex and includes many mechanisms [71]
such as oxidative modifications of macromolecules by ROS [72], signaling through lipid peroxidation
and their products [73] and involvement of different transcription factors (i.e., mentioned above
FOXOs and Nrf2) [74,75]. Considering ubiquitous expression of these transcription factors as
well as their crucial cellular functions it is very difficult to modulate them by pharmacological
interventions [72,76]. Similarly, lipid peroxidation products play important physiological functions,
for example in gastrointestinal tract [77]. Considering the significance of the regulatory functions of
4-hydroxynonenal and other lipid peroxidation products they also start attracting interest as a target
for pharmacological interventions in major stress-associated disorders [78].
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7. The Evidence from Glucose-6 Phosphate Dehydrogenase Deficiency
G6PD deficiency is one of the most common genetic human diseases and affects more than 400
million people worldwide [18], therefore, much can be learned from the published evidence. Since
G6PD is a gateway to such an important metabolic pathway as the PPP, dramatic consequences to the
patients could be expected. However, this is very often not the case. As was already mentioned in
the introductory section, these patients have few or no symptoms, with generally positive prognoses
and their expected lifespan is no different than that of the general population [18]. There are two
basic explanations for this evidence: first, most of the patients have a moderate degree of G6PD
deficiency and the PPP is still functioning at some level and, also, alternative pathways generate
sufficient amounts of NADPH; second, humans with modern lifestyles are exposed to relatively low
intensity stressors and there is simply no need for acute responses to stress. In contrast, severe G6PD
deficiency does indeed have a detrimental effect on the immune system and causes higher susceptibility
to infections [79]. In addition, G6PDH-deficient athletes and patients with this genetic defect may have
severe hemolytic crises after physical exertion [80]; however, the severity of susceptibility of individual
subjects may vary widely [81]. Complete G6PD knockout in mammals is incompatible with life, but
in embryonic mice stem cells it led to the severe susceptibility of cells to oxidative stress induced
by hydrogen peroxide or diamide and reduced cloning efficiency. However, the later was restored
when the oxygen concentration was reduced [82]. Therefore, in conditions of substantial oxidative
challenge, the proper function of the PPP and generation of NADPH are essential for survival [83].
Conversely, G6PD overexpression may be expected to increase resistance to oxidative stress. Indeed,
recent reports indicate that G6PD overexpression extends the lifespan of Drosophila melanogaster [84],
which is consistent with some of the results obtained using a G6PD overexpressing mouse model, where
it leads to the extension of the health-span of mice and increased resistance to oxidative damage [85].
8. Redox Dependence of Pancreatic Regulation of Blood Glucose Levels
A growing body of evidence indicates that the release of insulin from pancreatic β-cells depends
on the function of the PPP. It was shown that insulin levels in G6PD deficient patients are lower
compared to unaffected controls, and these patients have significantly reduced insulin responses to
the elevation of blood glucose [86]. More recently, with the use of metabolomics approach it was
shown that insulin release is controlled by the direct implication of the PPP [87]. According to a recent
review, among the most important amplifiers/regulators of insulin secretion by β-cells are high levels
of NADPH and glutathione [88]. So, insulin release is taking place in conditions of “metabolic welfare”
and oxidative stress may reduce the ability of β-cells to release insulin [89]. α-сells also have their
intrinsic mechanisms of glucose sensing relying on intracellular redox balance, but they are activated
by pro-oxidant situations [90]. Interestingly, under physiological conditions β-cells do not accumulate
glycogen but are able to do so under prolonged hyperglycemia and may prolong insulin secretion
even after normalization of glucose concentration. In contrast, α-cells do not accumulate glycogen,
so when the concentration of blood glucose drops, they can be quickly activated without delay [91],
which is extremely important in case of emergencies such as hypoglycemia.
One may argue that there are many other mechanisms for the regulation of insulin and
glucagon that can either enhance or inhibit respective secretion, including paracrine δ-cells secreting
somatostatin [92,93], effects of glucagon-like peptide-1 (GLP-1) [94], glucose-dependent insulinotropic
peptide (GIP) [95], leptin/adiponectin axis [96], and autonomic nervous system [97,98]. However, the
effects of all these regulators are integrated at the level of α- and β-cells and their metabolism resulting
shifts of redox potential [87,88,90].
9. Inflammation, Insulin Resistance and Redox Homeostasis
NADPH produced by the PPP or by other pathways is also used by NADPH oxidases and nitric
oxide synthase to produce superoxide anion. This is important for proper functioning of the immune
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system and for redox regulation of multiple processes in the tissues including endothelial function [99].
It was shown, that pro-inflammatory interleukin 1β enhances glucose uptake under hyperglycemic
conditions in cultured human aortic smooth muscle cells. It also activates PPP and promotes the
production of superoxide by NADPH oxidase contributing to vascular damage [100] pointing out a
particularly dangerous combination of inflammation and hyperglycemia. Since immune cells require
glucose for their function, they send regulatory signals, for example TNF-α [101] or microRNAs [102] to
the liver to enhance hepatic glucose output and thus, chronic inflammatory conditions may cause insulin
resistance [103]. The opposite effects are mediated by anti-inflammatory interleukin-10 [104] and the
spleen plays a particularly important role in these regulatory interactions [105]. The autonomic nervous
system may also be involved in regulation of interactions of local inflammatory conditions and oxidative
stress [106]. Autonomic output is actively involved in the regulation of glucose homeostasis and can
adjust the rates of glucose production and utilization independently of hormonal influences [107]. The
healing of oxidative stress-associated conditions, therefore, may improve autonomic balance [108].
Chronic carbohydrate overload and reduced physical activity cause obesity and metabolic syndrome,
and for these conditions, insulin resistance is very typical [109]. Thus, there exist complex multilevel
regulatory interactions to provide a sufficient flow of glucose to tissues in order to maintain a redox
balance. Prompt adjustments of redox homeostasis are critical for the immune defense where the PPP
plays a major role. Insulin resistance developing in this case seems to be adaptive and to some extent a
protective mechanism [110], but, if dysregulated, it leads to detrimental health consequences.
10. Glucose—“Oxidant” or “Antioxidant” after All? Sola Dosis Facit Venenum
There is a certain degree of confusion in the literature concerning the role of glucose in the
maintenance of redox homeostasis. It was long known, that diabetes and hyperglycemia obviously
cause redox dysregulation, oxidative stress and accelerated ageing [111]. On the other hand, glycogen
clearly protects against the oxidative stress and at the same time decreases lifespan and health
span [50,112]. Starvation and stress-induced gluconeogenesis clearly support survival and improve
health and lifespans [112,113], but are associated with the increased generation of ROS [40]. Moreover,
the complete withdrawal of glucose hence leads to short-term fall in ATP production, and surprisingly
causes a rise in ATP and increased mitochondrial content shortly after that is associated with the
activation of the protein deacetylase SIRT1. At the same time increased ROS production or possibly
insufficient ROS utilization is documented [114]. This suggests that there are a variety of effective
metabolic adaptations to compensate lack of glucose for ATP production, but a subsequent deficit of
reducing power to counteract to increase in ROS production is much more difficult to compensate.
Exercise, intermittent fasting/caloric restriction all lead to functional glucose/glycogen depletion
through activation of autophagy and support healthy aging that requires certain degree of oxidative
stress that leads to metabolic shift to catabolism and activate endogenous protective mechanisms that
include enhanced protein quality control, stimulation of endogenous antioxidant defense including
gluconeogenesis [57,111,115].
The other interesting aspect of glucose involvement in redox homeostasis is that supraphysiological
concentrations of glucose in the cells may actually lead to the increased production of hydrogen
peroxide by mitochondria through the inhibition of mitochondria-bound hexokinase [116]. Similarly,
chronically high levels of NADPH may contribute to the enhanced generation of superoxide and/or
hydrogen peroxide by NADPH-oxidases (NOX) as well as enhance the reduction in glucose in polyol
pathway (Figure 2) [99]. Involvement of NOX in regulation and maintenance of redox homeostasis
is very complex and depends on its isoforms that are expressed differently in tissues. For example,
cardiomyocytes express NOX2 and NOX4 isoforms and use the generation of hydrogen peroxide
for the regulation of cellular metabolism and contractile function (NOX4 activation acts similarly
as beta-blockers decreasing inotropy) [117]. NOX isoforms are increasingly studied as potential
therapeutic targets in order to modulate redox balance in the cells during cardiovascular and metabolic
diseases [118].
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Diabetes, both type 1 and 2 are well documented diseases associated with oxidative stress.
The fundamental feature of diabetes is chronic hyperglycemia due to excessive glucose production
and/or impaired its utilization by the tissues. There are several mechanisms contributing to oxidative
stress in conditions of hyperglycemia that include but are not limited to non-enzymatic glycation
and formation of advanced glycation products, the activation of polyol pathway that results in
a depletion in NADPH (decreased rate of enzymatic reduction in oxidized glutathione and thiol
groups of proteins), an increase in NADH and a depletion in NAD+ (increased superoxide anion
production in mitochondria), the inhibition of histone deacylation and excessive histone acetylation
due to the accumulation of acetyl-CoA, as well as the generation of excessive amounts of sorbitol and
fructose [119].
Taken together, the evidence indicates that there exists a delicate balance between the protective
and damaging redox effects of glucose and chronic dietary carbohydrate overload may affect the
regulatory mechanisms that developed during evolution to maintain redox homeostasis (Figure 3).
Bell-shaped antioxidant activity of glucose explains well necessity to regulate it strictly within the
narrow range, while both excessively high and/or low levels of glucose/carbohydrates lead to oxidative
and metabolic stress that quickly becomes damaging [120]. The dysregulation of glucose metabolism
that takes place in diabetes closes vicious cycle further exacerbating redox dysregulation that was
actually meant to be fixed by induction of hyperglycemia.
Antioxidants 2020, 9, x FOR PEER REVIEW 11 of 20 
narrow range, while both excessively high and/or low levels of glucose/carbohydrates lead to 
oxidative and metabolic stress that quickly becomes damaging [120]. The dysregulation of glucose 
metabolism that takes place in diabetes closes vicious cycle further exacerbating redox dysregulation 
that was actually meant to be fixed by induction of hyperglycemia. 
 
Figure 3. The dependence of redox effects of glucose on its concentration (hypothetic relationship 
suggested by the authors). Hypothetical simplified model describing the influence of the blood 
concentration of glucose on redox potential in human organisms. Multiple additional factors 
influencing redox potential such as concentration of oxygen, availability of amino and fatty acids, 
type of cells and effects of either hormones (insulin, glucagon) or cytokines are not considered. 
Concentrations of glucose as well as the shape of the curve are roughly estimated and not confirmed 
by actual experiments and may significantly vary depending on conditions and tissue type. 
11. Important Implications 
Glucose is a central metabolite and depending on its availability and metabolic need can play 
different roles in the organism. Glucose flows within the human body are strictly regulated and 
promptly adjustable in order to maintain metabolic flexibility and provide robust resistance to 
different types of stressing factors (Figure 4). The role of glucose is not limited to merely generating 
enough ATP (which is the case in conditions of glucose abundance and low stress), but more 
importantly, it is responsible for the emergency mechanisms of the maintenance of redox potential 
that is essential for survival in extreme situations (fight or flight reactions, infections, and poisoning). 
Since TCA-cycle reactions and oxidative phosphorylation can be effectively maintained in 
almost absence of glucose by oxidation of fatty and amino acids, its residual amounts are—in 
catabolic conditions—redirected into the PPP to maintain redox balance in the cells. At the same time, 
the anabolic state requires redirecting excess glucose into energy production and biosynthesis 
(growth, proliferation, hypertrophy), when the primary life-supporting and life preserving needs 
ensured by glucose have already been met (“survival—first, growth—follows”). The proposed 
principle is helpful for understanding the regulation of glucose metabolism aimed primarily to 
maintain redox balance, especially in acute extreme conditions requiring prompt and massive 
antioxidant responses. Oxidative stress, infections/inflammation, starvation, exercise, aging and 
many other pathological conditions or processes decrease GSH/GSSG and NADPH/NADP+ ratios. 
Figure 3. The dependence of redox effects of glucose on its concentration (hypothetic relationship
suggested by the authors). Hypothetical simplified model describing the influence of the blood
concentration of glucose on redox potential in human organisms. Multiple additional factors influencing
redox potential such as concentration of oxygen, availability of amino and fatty acids, type of cells
and effects of either hormones (insulin, glucagon) or cytokines are not considered. Concentrations of
glucose as well as the shape of the curve are roughly estimated and not confirmed by actual experiments
and may significantly vary depending on conditions and tissue type.
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11. Important Implications
Glucose is a central metabolite and depending on its availability and metabolic need can play
different roles in the organism. Glucose flows within the human body are strictly regulated and
promptly adjustable in order to maintain metabolic flexibility and provide robust resistance to different
types of stressing factors (Figure 4). The role of glucose is not limited to merely generating enough
ATP (which is the case in conditions of glucose abundance and low stress), but more importantly, it is
responsible for the emergency mechanisms of the maintenance of redox potential that is essential for
survival in extreme situations (fight or flight reactions, infections, and poisoning).
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Figure 4. Role of redox sensors (pancreatic α and β cells), immune system and central nervous system
in the regulation of blood glucose concentrations by liver. Glucose release or absorption by the liver
integrates signals from nervous and immune systems, and peripheral redox sensors. The system is
highly flexible and tunable, providing redox modulation that is dependent on actual needs. The other
way around, glucose flows and redox state regulate the function of immune system [121]. Failure of
feedback loops and distorted signaling—either from CNS (stress), the immune system (inflammation)
or the malfunction of peripheral sensors—lead to excessive, uncontrolled (poorly controlled) glucose
release and/or the activation of gluconeogenesis, leading to diabetes.
Since TCA-cycle reactions and oxidative phosphorylation can be effectively maintained in almost
absence of glucose by oxidation of fatty and amino acids, its residual amounts are—in catabolic
conditions—redirected into the PPP to maintain redox balance in the cells. At the same time, the
anabolic state requires redirecting excess glucose into energy production and biosynthesis (growth,
proliferation, hypertrophy), when the primary life-supporting and life preserving needs ensured
by glucose have already been met (“survival—first, growth—follows”). The proposed principle is
helpful for understanding the regulation of glucose metabolism aimed primarily to maintain redox
balance, especially in acute extreme conditions requiring prompt and massive antioxidant responses.
Oxidative stress, infections/inflammation, starvation, exercise, aging and many other pathological
conditions or processes decrease GSH/GSSG and NADPH/NADP+ ratios. Sensors sense these changes
and drive glucose flows to compensate for these metabolic disturbances at the organismic level.
In this regard insulin resistance develops as a protective “antioxidant” adaptive mechanism that
stimulates glucose production and prevents its waste in order to cope with increased needs. When
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dysregulated and chronically over-activated, though, this leads to detrimental consequences caused by
hyperglycemia [110].
The other important issue, which is often not taken into consideration by researchers, is that the
presence of glucose stores in the form of glycogen or extracellular glucose availability provide enhanced
resistance to oxidative stress. It is also possible that glucose—by strengthening the reductive power of
NADPH-dependent antioxidant enzymes—prevents the activation of redox-sensitive regulatory factors
such as Nrf2. That means that glucose nutritional overload affects physiological redox signaling, and
the chronic over-activation of insulin signaling causes metabolic diseases, as described in detail [24].
On the other hand, severe glucose overload itself can serve as a source of oxidative stress in the cells
through the participation of glucose in polyol pathway, over-the activation of NADPH oxidases and
increased production of ROS by mitochondria. Exercise, caloric restriction, intermittent fasting, a
ketogenic diet and some drugs have something in common—in that they deplete organisms’ glycogen
stores [44], reduce glucose availability for the cells, restore the physiological redox signaling suppressed
by chronic excessive glucose consumption and lead to a dramatic improvement of life- and health-spans
in model organisms and humans (Figure 2). Metabolic changes caused by carbohydrate overload in
the general population often take place far before clinically significant changes occur [43]. That is why
relevant and sensitive instruments for the early detection of these metabolic shifts are needed.
12. Limitations of the Analysis and Directions of Further Research
In this review we presented mainly general principles of glucose metabolism in the cells and
its importance for maintenance of redox balance. However, different cells in different tissues have
their specific metabolic patterns, specific functions, and own physiological peculiarities. We tried
to focus on the most important findings and inconsistencies in the literature from our point of view
rather than focusing on biochemical details, different pathways, tissue differences and to show how
the clinical and experimental evidence may be interpreted when the glucose will be considered as
redox mediator rather than simply fuel “burned” to generate ATP. Glucose metabolism may differ
substantially depending on the specifics of tissues and cells, proliferation activity, redox balance
required to maintain the functions, expression and activities of involved enzymes. It is not possible to
accurately describe all the evidence that is published in the literature, and we are aware that many
important details may be missing from our analysis. Nevertheless, we hypothesize that convincing
literature evidence indicates that glucose flows in the organism are primarily targeted to maintain
redox homeostasis and counteract possible oxidative challenges.
It may be argued that the actual flow through PPP is relatively low in the brain (as has been
shown by Gaitonde M. et al. [122]) and it only increases substantially to approximately 20% of total
glucose utilization by neurons in cases of severe oxidative stress induced by hydrogen peroxide [123]
or during experimental brain injury [124]. However, a closer look into the methods used in the studies
reveals that non-physiologically high concentrations of glucose were used, namely 22.3 mM in the
medium and 50.0 mM for perfusion in [123] and 23.9–26.9 mM plasma glucose after infusion in [124]).
The flow of glucose into the PPP is inhibited in conditions of high NADPH/NADP+ ratio, therefore as
soon as the levels of NADPH are restored, glucose is redirected into glycolysis or glycogen storage.
Our reconsiderations may provide better understanding of the physiology of glucose regulation
in health and diseases and lead to the shift of the general paradigm of glucose-induced oxidative
stress—which is, however true for hyperglycemia and diabetes—towards understanding the redox
effects of glucose in a concentration-dependent manner. In other words, glucose maintenance at
physiological levels is a fundamental mechanism of counteracting excessive oxidation due to its
involvement in PPP and NADPH production. Endogenous antioxidant systems using glucose provide
sufficient antioxidant defense in physiological conditions. Moreover, redox modulating agents that
have some health benefits when supplemented often turn out to be rather prooxidant than antioxidant,
and lead to the stimulation of endogenous antioxidant defenses and the improvement of glucose
metabolism. Therapeutic approaches to applying antioxidant substances in order to reduce oxidative
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damage and the administration of compounds with the pure purpose to provide reducing equivalents
appears weak [125] in contrast to often-high in vitro activities [126], and in comparison to existing
endogenous antioxidant mechanisms based on glucose as a source of reducing power for the generation
of NADPH and recycling oxidized glutathione and thiols, and can in some cases be deleterious since
they may interfere with redox sensors—for example protein thiol groups, and cause dysregulations.
The other important issue is the lack of convenient, informative, sensitive and specific ways of
glucose and/or glycogen determination in tissues for research and clinical use. As we suggested earlier,
glycogen determination, preferably in a simple, affordable and noninvasive way could potentially
be a good biomarker for redox biomedicine [44]. Unfortunately, there are too many technical issues
preventing the development of such equipment for clinical use so far, but some efforts have been made
to enable label-free glycogen estimation in C. elegans, an important animal model for metabolic and
aging research [127].
13. Conclusions
Our critical analysis of the current literature unveiled significant controversies and an insufficient
general understanding of metabolic role of glucose, particularly regarding redox homeostasis.
The important function of glucose metabolism in the PPP for the maintenance of redox homeostasis is
very often underestimated. In light of recent epidemiological evidence and advancements in the field
of redox biology, it is hypothesized that a specific physiological function of glucose is its metabolism in
the PPP, to provide stress resistance to unfavorable factors by the reduction in NADP+ to NADPH
in order to maintain redox homeostasis and the correct functioning of immune cells. Meanwhile,
glycolysis takes place in favorable redox conditions when glucose is in abundance. This approach
and interpretation explains—in a simple way—the adverse metabolic effects and detrimental health
consequences of nutritional carbohydrate overload, and provides new details in explaining the positive
metabolic effects of intermittent fasting, caloric restriction, exercise, and a ketogenic diet. A better
understanding of the evolutionary adaptations and biological role of glucose may serve as an important
theoretical background for future experimental and clinical studies related to glucose metabolism,
aging, and diabetes, as well as other adjacent fields.
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